Literature DB >> 26880722

Vein of Galen aneurysmal malformation-clinical and angiographic spectrum with management perspective: an institutional experience.

Himanshu Agarwal1, Leve Joseph Devarajan Sebastian1, Shailesh B Gaikwad1, Ajay Garg1, Nalini K Mishra1.   

Abstract

BACKGROUND AND
PURPOSE: Vein of Galen aneurysmal malformation (VGAM) is a rare developmental intracranial vascular malformation. We analyzed the clinical presentations, imaging findings, angioarchitecture, management options, and outcome in a demographically heterogeneous set of VGAM patients.
METHODS: We retrospectively analyzed cases of VGAM from our departmental archive collected between 1988 and January 2015. Demographic, clinical, therapeutic, and follow-up details were obtained for each patient from the available records.
RESULTS: We identified 36 patients with VGAM including 6 neonates, 18 infants, 7 children aged 2-10 years, and 5 adults. Macrocrania was the commonest presenting feature. Type of fistulae was mural in 14 and choroidal in 18 patients while 4 had a thrombosed sac at presentation. In 3 cases the dilated venous sac had connection with the deep venous system. Bilateral jugular atresia and stenosis were seen in 9 and 6 patients, respectively. Giant venous sac (>4 cm) was significantly correlated with mural type (p=0.0001). Dural arterial recruitment was seen in 4 patients including 3 adults. Among the 23 patients treated by endovascular means, 14 had a good outcome, 5 had a poor outcome, and 4 died. A significant correlation was noted between jugular atresia and poor outcome (p=0.003).
CONCLUSIONS: We encountered a wide range of demographic, clinical, and angiographic features in VGAM. Mural type malformations were associated with giant venous sacs. Good outcome after embolization was seen in selected neonates and in most of the infants, children, and adults. Jugular atresia was significantly associated with poor outcome. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Arteriovenous Malformation; Congenital; Intervention; Pediatrics

Mesh:

Year:  2016        PMID: 26880722     DOI: 10.1136/neurintsurg-2015-012137

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  6 in total

1.  Occlusion of a mural type vein of Galen malformation in a 10-month-old boy with three Woven EndoBridge (WEB 17) and two coils.

Authors:  Frank Runck; Christoph J Maurer; Markus Bode; Harald Lochbihler; Adisa Kuršumović; Ansgar Berlis
Journal:  BMJ Case Rep       Date:  2019-04-14

2.  Superselective transvenous embolization with Onyx and n-BCA for vein of Galen aneurysmal malformations with restricted transarterial access: safety, efficacy, and technical aspects.

Authors:  Kirill Orlov; Anton Gorbatykh; Vadim Berestov; Timur Shayakhmetov; Dmitry Kislitsin; Pavel Seleznev; Nikolay Strelnikov
Journal:  Childs Nerv Syst       Date:  2017-07-08       Impact factor: 1.475

3.  Fine, Vascular Network Formation in Patients with Vein of Galen Aneurysmal Malformation.

Authors:  T Shigematsu; M J Bazil; J T Fifi; A Berenstein
Journal:  AJNR Am J Neuroradiol       Date:  2022-09-22       Impact factor: 4.966

Review 4.  Intracranial non-galenic pial arteriovenous fistula: A review of the literature.

Authors:  Jinlu Yu; Lei Shi; Xianli Lv; Zhongxue Wu; Hongfa Yang
Journal:  Interv Neuroradiol       Date:  2016-07-06       Impact factor: 1.610

Review 5.  Imaging Characteristics of Dural Arteriovenous Fistulas Involving the Vein of Galen: A Comprehensive Review.

Authors:  Mohammad W Kassem; Paul J Choi; Joe Iwanaga; Martin M Mortazavi; R Shane Tubbs
Journal:  Cureus       Date:  2018-02-11

6.  Role of endovascular embolisation for curative treatment of intracranial non-Galenic pial arteriovenous fistula.

Authors:  Hengwei Jin; Xiangyu Meng; Jiale Quan; Yi Lu; Youxiang Li
Journal:  Stroke Vasc Neurol       Date:  2020-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.